Page 321 - HIVMED_v21_i1.indb
P. 321

Page 7 of 7  Original Research


              The  weakness  of  the  study  was the  use  of  cross-sectional   Disclaimer
              study design that prevents  long-term follow-up  of   The views and opinions expressed in this article are those of
              participants and the absence of ‘hard’ clinical end points –   the authors and not necessarily reflect the official policy or
              actual BP, glucose monitoring and viral load suppression of
              the study cohort over time – to support the contention that   position of any affiliated agency of the authors.
              the care of this group of Zimbabwean patients  is being
              compromised.                                          References
                                                                    1.  Joint  United  Nations  Programme  on  HIV/AIDS  (UNAIDS).  Global  HIV  &  AIDS
              Conclusion                                              statistics – 2018 fact sheet [homepage on the Internet]. UNAIDS; 2018. Available
                                                                      from: https://www.unaids.org/en/resources/fact-sheet
              Findings from this study demonstrate that the observed   2.  World  Health  Organization.  Working  Group  on  the  inclusion  of  NCDs  in  other
                                                                      programmatic areas: WHO global coordination mechanism on the prevention and
              incidence and prevalence of HTN and DM among PLWH in    control of non-communicable diseases (Working group 3.1, 2016–2017). Geneva:
              Gweru district is a function of the capacity of its healthcare   World Health Organization; 2018.
              system to screen for and adequately manage NCDs. Given   3.  Magodoro IM, Esterhuizen TM, Chivese T. A cross-sectional, facility based study of
                                                                      comorbid non-communicable diseases among adults living with HIV infection in
              the ageing population of PLWH in SSA, coupled with the   Zimbabwe. BMC Res Notes. 2016;9(1):379. https://doi.org/10.1186/s13104-016-
                                                                      2187-z
              growing prevalence of NCDs in this group, HIV programmes   4.  Mutede  BR,  Magure  T,  Gombe  NT,  Bangure  D,  Tshimanga  M.  Prevalence  and
              require strengthening. While  the social  and economic   factors associated with hypertension among anti-retroviral therapy patients aged
              problems of Zimbabwe are dire, this study gives voice to   15  years  and  above  in  Makonde  District,  Zimbabwe,  2012:  An  analytic  cross
                                                                      sectional study. World J Cardiovasc Dis. 2015;5(9):266. https://doi.org/10.4236/
              some of its PLWH. We feel that this is a voice that others need   wjcd.2015.59030
              to hear too.                                          5.  Smit M, Olney J, Ford NP, et al. The growing burden of non-communicable disease
                                                                      among persons living with HIV in Zimbabwe. AIDS. 2018;32(6):773. https://doi.
                                                                      org/10.1097/QAD.0000000000001754
              Acknowledgements                                      6.  Lazarus JV, Olsen M, Ditiu L, Matic S. Tuberculosis – HIV co-infection: Policy and
                                                                      epidemiology  in  25  countries  in  the  WHO  European  region.  HIV  Med.  2008;
              Competing interests                                     9(6):406–414. https://doi.org/10.1111/j.1468-1293.2008.00567.x
                                                                    7.  Ministry  of  Health  and  Child  Care  (MoHCC).  The  National  Health  Strategy  for
              The authors declare that they have no financial or personal   Zimbabwe  (2016-2020):  Equity  and  quality  in  health:  leaving  no  one  behind.
                                                                      Harare: Ministry of Health and Child Care; 2016 [cited no date]. Available from:
              relationships that may have inappropriately influenced them   https://malariaelimination8.org/wp-content/uploads/2017/02/National%20
              in writing this research article.                       Health%20Strategy%20for%20Zimbabwe%202016-2020.pdf
                                                                    8.  Zimbabwe  population-based  HIV  impact  assessment:  ZIMPHIA  2015–2016,  Final
                                                                      Report [homepage on the Internet]. ICAP at Columbia University. 2019 [cited 2020 Feb
              Authors’ contributions                                  5]. Available from: https://phia.icap.columbia.edu/wp-content/uploads/2019/08/
                                                                      ZIMPHIA-Final-Report_integrated_Web-1.pdf
              All authors contributed equally to this work.         9.  Marshall MN. Sampling for qualitative research. Family Prac. 1996;13(6):522–526.
                                                                      https://doi.org/10.1093/fampra/13.6.522
                                                                    10. Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation:
              Ethical consideration                                   How many interviews are enough? Qual Health Res. 2017;27(4):591–608. https://
                                                                      doi.org/10.1177/1049732316665344
              Ethical approval for this study was obtained from the University   11. Aschengrau A, Seage GR. Essentials of epidemiology in public health. Sudbury,
                                                                      Massachusetts: Jones & Bartlett Publishers; 2013.
              of KwaZulu-Natal Biomedical Research Ethics Committee   12. Mungati  M,  Manangazira  P,  Takundwa  L,  et  al.  Factors  affecting  diagnosis  and
              (Ethical Clearance Number: BE086/19) and the Ministry of   management  of  hypertension  in  Mazowe  District  of  Mashonaland  Central
                                                                      Province in Zimbabwe: 2012. BMC Cardiovasc Disord. 2014;14(1):102. https://doi.
              Health and Child Care Head office in Harare. Participation in   org/10.1186/1471-2261-14-102
              the study was voluntary. Written informed consent was sought   13. Peltzer  K.  Utilization  and  practice  of  traditional/complementary/alternative
              from potential participants, and confidentiality was maintained   medicine  (TM/CAM)  in  South  Africa.  Afr  J  Tradit  Complemen  Altern  Med.
                                                                      2009;6(2):175.
              throughout the study by removal of personal identifiers after   14. Chamie G, Kwarisiima D, Clark TD, et al. Leveraging rapid community-based HIV
              entry into the electronic database and use of non-identifiable   testing  campaigns  for  non-communicable  diseases  in  rural  Uganda.  PLoS  One.
                                                                      2012;7(8):e43400. https://doi.org/10.1371/journal.pone.0043400
              coded numbers. All data were password-protected and stored   15. Chhoun  P,  Tuot  S,  Harries  AD,  et  al.  High  prevalence  of  non-communicable
              in the electronic participant database.                 diseases  and  associated  risk  factors  amongst  adults  living  with  HIV  in
                                                                      Cambodia.  PLoS  One.  2017;12(11):e0187591.  https://doi.org/10.1371/journal.
                                                                      pone. 0187591
              Funding information                                   16. Coetzee L, Bogler L, De Neve JW, Bärnighausen T, Geldsetzer P, Vollmer S. HIV,
                                                                      antiretroviral  therapy  and  non-communicable  diseases  in  sub-Saharan  Africa:
              The research received funding from University of KwaZulu-   Empirical evidence from 44 countries over the period 2000 to 2016. J Int AIDS Soc.
                                                                      2019;22(7):e25364. https://doi.org/10.1002/jia2.25364
              Natal, under PhD research grant.
                                                                    17. Mc Conalogue D, Nxumalo B, Busawa-la F, Sharp A, Walley J. Implementation of a
                                                                      non-communicable  disease  (NCD)  screening  programme  in  a  rural  African  HIV
                                                                      clinic. HIV/AIDS Res Treat Open J. 2017;4(1):32–39.
              Data availability statement                           18. Patel P, Speight C, Maida A, et al. Integrating HIV and hypertension management
                                                                      in low-resource settings: Lessons from Malawi. PLoS Med. 2018;15(3):e1002523.
              Because of the private nature of the data, data for the study   https://doi.org/0.1371/journal.pmed.1002523
              will be available only upon request and approval of   19. Pfaff C, Scott V, Hoffman R, Mwagomba B. You can treat my HIV-but can you treat
              Authorising Ministry of Health.                         my blood pressure? Availability of integrated HIV and non-communicable disease
                                                                      care in northern Malawi. Afr J Prim Health Care Fam Med. 2017;9(1):1–8.








                                           http://www.sajhivmed.org.za 313  Open Access
   316   317   318   319   320   321   322   323   324   325   326